Promising Results of CRS/HIPEC Treatment
A new treatment can lead to good short- and long-term outcomes for patients with mesothelioma. It’s called cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS/HIPEC). Research results came from the Medical University of Vienna in Austria. They looked at the first 100 mesothelioma patients who had this treatment in their hospital. Advancing Mesothelioma Care Mesothelioma is a rare form of cancer that grows in the lining that covers many of the internal organs of the body. Mesothelioma is caused by exposure to asbestos. There are approximately 2,000 cases of mesothelioma diagnosed in the United States every year. The standard treatment for mesothelioma usually includes surgery, chemotherapy, and radiation. The typical prognosis with standard treatment is survival between one and five years. … Continue reading Promising Results of CRS/HIPEC Treatment
Discovering the Link to Mesothelioma Growth
Italian researchers have found that a molecule called cycle adenosine monophosphate (cAMP) is involved in the growth of mesothelioma. cAMP acts as a messenger in our cells and affects different processes in the body. When the cAMP pathway is too active, it can contribute to the growth and spread of tumors. In this study, researchers looked at the levels of cAMP in mesothelioma tumors caused by toxic fibers like asbestos. Mesothelioma is an aggressive cancer that grows on the lining of internal organs like the lungs and abdomen. It is caused by exposure to asbestos. Asbestos is a naturally occurring mineral that is toxic to humans. Mesothelioma is a rare disease, so we do not know very much about how … Continue reading Discovering the Link to Mesothelioma Growth
Revolutionizing Mesothelioma Diagnosis: Breakthrough Blood Test Method
A study conducted by researchers from China is the first to use a new method to analyze blood samples of people with mesothelioma. The method is called gas chromatography-mass spectrometry (GC-MS). The researchers were hoping that this method would help them find mesothelioma biomarkers in blood samples. A Promising Step Forward Mesothelioma is a type of cancer that develops from the thin layer of tissue that covers many of the body’s internal organs. Pleural mesothelioma grows in the lungs. Peritoneal mesothelioma grows in the abdomen. This cancer is caused by exposure to a toxic material called asbestos. Mesothelioma is usually diagnosed after a person goes to a doctor because they are experiencing symptoms. These symptoms depend on the type of … Continue reading Revolutionizing Mesothelioma Diagnosis: Breakthrough Blood Test Method
Hope and Resilience: A Case of Mesothelioma Long-Term Survival
A new study highlights how important early diagnosis and effective treatment are to long-term survival. Malignant peritoneal mesothelioma is a type of cancer caused by asbestos. It develops in the abdominal cavity. This cancer occurs in less than 1,000 people in the United States every year. The Importance of Early Detection Symptoms of mesothelioma may take decades after asbestos exposure to appear in the affected person. Most of the common symptoms occur around the abdomen, like pain and swelling. Other symptoms could be night sweats and fever. To diagnose mesothelioma, doctors will usually use a combination of scans and biopsies. Treatment for mesothelioma can include surgery, chemotherapy, and radiation. A Japanese Case Study on Long-Term Survival In this case, a … Continue reading Hope and Resilience: A Case of Mesothelioma Long-Term Survival
The Power of Drug Combinations: High Throughput BH3 Profiling in Mesothelioma
A new technique called dynamic BH3 profiling tests drug combinations to treat mesothelioma. This testing can help doctors create effective treatment plans for individual patients. Mesothelioma is a type of cancer caused by exposure to asbestos. It is hard to diagnose and even harder to treat, especially when it is in advanced stages. Even in the early stages, the chances of survival after five years are only 18%. A Treatment Plan for Mesothelioma A treatment plan for malignant pleural mesothelioma depends on a few different factors. These include the type of mesothelioma and how far it has developed in the patient. It may also include the health of the patient and the patient’s wishes for treatment. Conventional treatment usually involves … Continue reading The Power of Drug Combinations: High Throughput BH3 Profiling in Mesothelioma
Genetic Counseling for Mesothelioma: What You Need to Know
People with a family history of thoracic cancers like mesothelioma should think about getting genetic counseling. This is the recommendation of researchers from the United States and the United Kingdom. They explored what we know about how changes in a person’s genes passed down through their family can increase their chances of developing cancer. The Power of Genetic Knowledge Mesothelioma is a type of cancer that is caused by exposure to asbestos. It most often occurs in the lungs or in the abdominal cavity. With the best conventional treatments, people with this cancer typically have a median survival of a little over a year for mesothelioma in the lungs and about five years for mesothelioma in the abdomen. There is … Continue reading Genetic Counseling for Mesothelioma: What You Need to Know
Identifying Mesothelioma: How Extracellular Vesicles Could Be the Key
Scientists believe that particles called extracellular vesicles could be used as biomarkers to identify malignant pleural mesothelioma (MPM). Malignant pleural mesothelioma is an aggressive and deadly cancer that affects the lining of the lungs and chest cavity. It is caused by exposure to asbestos, usually at work. It has a low survival rate, so it is important to find ways to diagnose it early. It is also important for doctors to be able to predict how it will develop in patients. How Mesothelioma is Diagnosed Mesothelioma is usually diagnosed after a person goes to a doctor because they are experiencing symptoms. For MPM, a person might feel shortness of breath due to fluid around the lung, chest pain, cough, and … Continue reading Identifying Mesothelioma: How Extracellular Vesicles Could Be the Key
Predicting Outcomes for People with Malignant Pleural Mesothelioma
A new study has found that a prognostic score based on the activity of just two genes could be useful in predicting outcomes for people with malignant pleural mesothelioma (MPM). The study was published the journal Diagnostics and was conducted by scientists from Bulgaria. Early Detection is Key for Better Outcomes Malignant pleural mesothelioma is a rare type of cancer that affects the lining of the lungs and chest called the pleura. It usually happens when a person has been exposed to asbestos. This is a harmful mineral that can be used in buildings and other materials. When asbestos fibers are inhaled, they can get trapped in the pleura and over time, cause cancer to develop. The cancer cells in … Continue reading Predicting Outcomes for People with Malignant Pleural Mesothelioma
Hemithoracic Radiotherapy for Mesothelioma
A type of radiation therapy called hemithoracic radiotherapy could be safely used as part of the treatment plan for patients with malignant pleural mesothelioma (MPM). Malignant pleural mesothelioma is a type of cancer that develops from the thin layer of tissue that covers the lungs and chest wall. This cancer is caused by exposure to asbestos. Pleural mesothelioma occurs in about 2,000 people in the United States every year. Diagnosis typically occurs in people over the age of 60, but pleural mesothelioma has occurred in people in their twenties. Surgery, Chemotherapy and Radiation A study conducted in Turkey looked at 11 patients with mesothelioma who received multimodal therapy. This type of treatment plan uses more than one type of therapy … Continue reading Hemithoracic Radiotherapy for Mesothelioma
Treatment Combination Used Most for Mesothelioma
Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) is being used by doctors to treat malignant peritoneal mesothelioma (MPM) more often. This is the finding of a study published in the Annals of Surgical Oncology. This is promising news because research has shown the CRS-HIPEC can be an effective treatment for patients with MPM. Mesothelioma Caused by Asbestos Exposure MPM is caused by exposure to a toxic material called asbestos. Most doctors believe it is caused from ingestion of asbestos fibers and that microscopic asbestos fibers become embedded in the abdomen. After about 20-50 years, these fibers can cause inflammation and mutations that ultimately caused tumors to form. This cancer occurs in less than 1,000 people in the United States … Continue reading Treatment Combination Used Most for Mesothelioma
Get your free copy of
“Surviving Mesothelioma” Today!